Definitive Contract 75F40119C10090
- Not listed
- This federal contract was awarded by the Food and Drug Administration (FDA) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract is for a study titled "Pediatric Pulmonary Hypertension Actigraphy Endpoint Clinical Study and Data Submission" with a ceiling value of $218,721.00. It is a definitive, firm fixed-price contract with a completion date of March 30, 2019. The contract does not have a set-aside designation. The...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract is for $370,032.00 and provides physical medical and rehabilitation research services. The contract has an ultimate completion date of January 31, 2026. The University of Colorado-Denver is a prominent public research university and state government entity that has extensive experience...
- The University of Colorado Denver, known as the University of Colorado-Denver, was awarded a $11,755,165.47 cost-reimbursement contract by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract, which runs through February 2026, does not have a set-aside designation. The contract is a definitive contract for the university to provide a variety of services and conduct research across disciplines including medicine,...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to The Regents of the University of Colorado, a U.S. state government entity and accredited public research university. The $149,952.00 contract does not have a set-aside designation and was awarded on September 25, 2017 with a completion date of September 24, 2019. As a prime contractor experienced in federal research and...
- This is a prime contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to The Regents of the University of Colorado, doing business as the University of Colorado Office of Contracts and Grants Division. The contract, valued at $35,044,058.95, is for biomedical research and development services and does not have a set-aside designation. The University of Colorado is an accredited public research university that conducts fundamental R&D...
- This is a $178,009.63 Firm Fixed Price definitive contract awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency, to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, for lung cancer research. The contract has an ultimate completion date of August 31, 2023 and does not have a set-aside designation. The University of Colorado-Denver is a major public research university that frequently receives federal funding through...
- The University of Colorado-Denver, a major public research university, was awarded a $2,280 firm-fixed-price purchase order by the Department of Veterans Affairs to conduct coronavirus research and efficacy studies. The contract does not have a set-aside designation. The University of Colorado-Denver is known for its medical research and has held various federal contracts and grants to support its work across disciplines. This award is associated with the university's broader research...
- This is a firm-fixed price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to conduct a high-intensity interval training (HIIT) study with veterans. The contract has a ceiling value of $6,510.41 and a period of performance ending on January 31, 2025. This contract does not have a set-aside designation. The University of Colorado-Denver is a major public research...
- The Defense Health Agency awarded a definitive contract to The Regents of the University of Colorado, doing business as the University of Colorado Denver, for $305,101.39 of research and development services through the agency's Broad Agency Announcement solicitation. The contract was awarded on September 24, 2018, with a completion date of September 23, 2020. It was not set aside for any special business types. The University of Colorado Denver is a public research university that conducts...
- The Regents of the University of Colorado, doing business as the University of Colorado-Denver, was awarded a federal contract by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to serve as a clinical research site for Phase I and II trials testing investigational medications for alcohol use disorder. The contract, which does not have a set-aside designation, is part of a multiple-award Indefinite Delivery Contract (IDC) with a $48 million ceiling value across all awardees,...
The Department of Health and Human Services Food and Drug Administration awarded a $720,000.00 firm fixed price contract to The Regents of the University of Colorado, doing business as the University of Colorado Denver, to conduct a study investigating the combination of physical activity and heart rate using actigraphy as an endpoint to facilitate pediatric pulmonary arterial hypertension trials and drug development. The contract was awarded on August 22, 2019 and has a completion date of February 28, 2022. No set-aside designation was used. The University of Colorado Denver is a public research university that provides educational services and conducts biomedical research. It has experience as both a prime and subcontractor on federal contracts and grants with agencies such as the Department of Veterans Affairs, Centers for Disease Control and Prevention, Department of Defense, and National Institutes of Health. This contract supports the FDA's mission to facilitate the development of new treatments for rare pediatric diseases.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science | FDABAA-19-00123 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Award Notice 1/1 | 10/18/18, 9:54 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $0 | 11/9/21 | |
| P00001 | Change Order | $0 | 8/31/21 | |
| Not listed | Not listed | $720.0k | 8/22/19 |